2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty Selected Research

Chronic Hepatitis (Chronic Active Hepatitis)

1/2020	Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡.
11/2019	Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty Research Topics

Disease

2	Hepatitis 01/2020 - 11/2019
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020 - 11/2019
2	Coinfection 01/2020 - 11/2019

Drug/Important Bio-Agent (IBA)

2	BilirubinIBA 01/2020 - 11/2019
2	Hepatitis B e AntigensIBA 01/2020 - 11/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 11/2019

Therapy/Procedure

2	Investigational Therapies (Experimental Therapy) 01/2020 - 11/2019